About this trial
This randomized clinical trial compares the survival rate and clinical performance of injectable bioactive giomer composite restorations versus the Hall Technique for managing proximal carious lesions (ICDAS 3-4) in primary molars of children aged 3-8 years over a 12-month follow-up period.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
• Generally showing cooperative behaviour that could be managed by the operators.
Willing to sign the informed consent.
Accepts the follow-up period.
Moderate to low caries risk according to cariogram application
Disqualifiers
• Allergy to any restorative materials.
Patients undergoing orthodontic treatment with fixed appliances.
Patients with debilitating systemic diseases.
Children with special needs.
Trial design
Parallel
Treatments tested in this trial
giomer
Other interventionrestoration of proximal cavities in primary molars using an injectable bioactive composite (Giomer) material. Cavities will be prepared following minimally invasive principles, isolated appropriately, and restored according to the manufacturer's instructions using adhesive bonding. Clinical performance will be evaluated in terms of retention, marginal adaptation, secondary caries, postoperative sensitivity, and overall restoration success during the follow-up period.
hall technique
Other interventionthe hall technique is a minimally invasive method used in paediatric dentistry to manage carious primary molars.it involves sealing the decay under e preformed stainless steel crown
Treatment groups
Trial outcomes
Primary outcomes
Restoration Survival Rate assessed by clinical and radiographic success/failure criteria (Innes et al., 2007)
Secondary outcomes
FDI criteria biological
Biological properties: recurrent caries and adjacent mucosa
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: